{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:55:33Z","timestamp":1786665333890,"version":"build-2736575974"},"reference-count":134,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH National Institute of Allergy and Infectious Diseases (NIAID)","award":["2R01AI093957"],"award-info":[{"award-number":["2R01AI093957"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Psoriasis is a long-lasting skin condition characterized by redness and thick silver scales on the skin\u2019s surface. It involves various skin cells, including keratinocytes, dendritic cells, T lymphocytes, and neutrophils. The treatments for psoriasis range from topical to systemic therapies, but they only alleviate the symptoms and do not provide a fundamental cure. Moreover, systemic treatments have the disadvantage of suppressing the entire body\u2019s immune system. Therefore, a new treatment strategy with minimal impact on the immune system is required. Recent studies have shown that sphingolipid metabolites, particularly ceramide and sphingosine-1-phosphate (S1P), play a significant role in psoriasis. Specific S1P\u2013S1P-receptor (S1PR) signaling pathways have been identified as crucial to psoriasis inflammation. Based on these findings, S1PR modulators have been investigated and have been found to improve psoriasis inflammation. This review will discuss the metabolic pathways of sphingolipids, the individual functions of these metabolites, and their potential as a new therapeutic approach to psoriasis.<\/jats:p>","DOI":"10.3390\/cells12192352","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T02:31:29Z","timestamp":1695695489000},"page":"2352","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Role of Sphingolipids and Sphingosine-1-phosphate\u2014Sphingosine-1-phosphate-receptor Signaling in Psoriasis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0425-6858","authenticated-orcid":false,"given":"Kana","family":"Masuda-Kuroki","sequence":"first","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-9337","authenticated-orcid":false,"given":"Shahrzad","family":"Alimohammadi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5575-9968","authenticated-orcid":false,"given":"Anna","family":"Di Nardo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","article-title":"Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures","volume":"84","author":"Elmets","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mahesh, P., Haque, M.A., Salman, B.I., Belal, T.S., Ibrahim, A.E., and El Deeb, S. (2023). Fast and Sensitive Bioanalytical Method for the Determination of Deucravacitinib in Human Plasma Using HPLC-MS\/MS: Application and Greenness Evaluation. Molecules, 28.","DOI":"10.3390\/molecules28145471"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"36207","DOI":"10.1074\/jbc.M104282200","article-title":"Ceramide inhibits axonal growth and nerve growth factor uptake without compromising the viability of sympathetic neurons","volume":"276","author":"Bussiere","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/intimm\/dxn100","article-title":"Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells","volume":"20","author":"Jin","year":"2008","journal-title":"Int. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1182\/blood-2002-09-2962","article-title":"Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation","volume":"101","author":"Jin","year":"2003","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehp387","article-title":"Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease","volume":"31","author":"Brakch","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","article-title":"The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer\u2019s Disease and Other Neurodegenerative Disorders","volume":"56","author":"Czubowicz","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tringali, C., and Giussani, P. (2022). Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147806"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbamem.2017.03.008","article-title":"Sphingosine 1-phosphate\u2014A double edged sword in the brain","volume":"1859","author":"Karunakaran","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12035-013-8622-4","article-title":"Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells","volume":"50","author":"Pyszko","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1523\/JNEUROSCI.6467-10.2011","article-title":"BACE1 activity is modulated by cell-associated sphingosine-1-phosphate","volume":"31","author":"Takasugi","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.wnl.0000327609.57688.ea","article-title":"FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis","volume":"71","author":"Mehling","year":"2008","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2000.tb06537.x","article-title":"Sphingosine 1-phosphate: A ligand for the EDG-1 family of G-protein-coupled receptors","volume":"905","author":"Spiegel","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1083\/jcb.114.1.155","article-title":"Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation","volume":"114","author":"Zhang","year":"1991","journal-title":"J. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4103\/0973-1482.126446","article-title":"Sphingosin 1-phosphate contributes in tumor progression","volume":"9","author":"Tabasinezhad","year":"2013","journal-title":"J. Cancer Res. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/1523-1747.ep12470233","article-title":"Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin?","volume":"96","author":"Imokawa","year":"1991","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100400","DOI":"10.1016\/j.jlr.2023.100400","article-title":"Effect of sphingosine and phytosphingosine ceramide ratio on lipid arrangement and barrier function in skin lipid models","volume":"64","author":"Rousel","year":"2023","journal-title":"J. Lipid Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Masuda-Kuroki, K., and Di Nardo, A. (2022). Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface. Biology, 11.","DOI":"10.3390\/biology11060809"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaci.2022.02.027","article-title":"Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections","volume":"150","author":"Berdyshev","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Masuda-Kuroki, K., Alimohammadi, S., and Di Nardo, A.S. (2023). Epidermidis Rescues Allergic Contact Dermatitis in Sphingosine 1-Phosphate Receptor 2-Deficient Skin. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713190"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12944-023-01813-3","article-title":"Pathogenic sphingosine 1-phosphate pathway in psoriasis: A critical review of its pathogenic significance and potential as a therapeutic target","volume":"22","author":"Zhao","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.2163543","article-title":"Intracellular calcium release mediated by sphingosine derivatives generated in cells","volume":"248","author":"Ghosh","year":"1990","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"14917","DOI":"10.1016\/S0021-9258(18)77204-9","article-title":"Ceramide 1-phosphate, a novel phospholipid in human leukemia (HL-60) cells. Synthesis via ceramide from sphingomyelin","volume":"265","author":"Dressler","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/abio.1997.2022","article-title":"[14C]ceramide synthesis by sphingolipid ceramide N-deacylase: New assay for ceramidase activity detection","volume":"247","author":"Mitsutake","year":"1997","journal-title":"Anal. Biochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0021-9258(18)96805-5","article-title":"The metabolism of sphingomyelin. I. Purification and properties of a sphingomyelin-cleaving enzyme from rat liver tissue","volume":"241","author":"Kanfer","year":"1966","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1074\/jbc.M409066200","article-title":"Selective inhibition of juxtanuclear translocation of protein kinase C betaII by a negative feedback mechanism involving ceramide formed from the salvage pathway","volume":"280","author":"Becker","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(90)90211-F","article-title":"An update of the enzymology and regulation of sphingomyelin metabolism","volume":"1044","author":"Merrill","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wollny, T., W\u0105tek, M., Durna\u015b, B., Niemirowicz, K., Piktel, E., \u017bendzian-Piotrowska, M., G\u00f3\u017ad\u017a, S., and Bucki, R. (2017). Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18040741"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-5793(97)01187-3","article-title":"Conversion of dihydroceramide to ceramide occurs at the cytosolic face of the endoplasmic reticulum","volume":"416","author":"Michel","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1126\/science.2555921","article-title":"Sphingomyelin synthase and PKC activation","volume":"246","author":"Hampton","year":"1989","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/j.1460-2075.1996.tb00595.x","article-title":"Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: Action through a specific cell surface receptor","volume":"15","author":"Postma","year":"1996","journal-title":"Embo J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hisano, Y., Kobayashi, N., Yamaguchi, A., and Nishi, T. (2012). Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038941"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/B978-0-12-394274-6.00008-X","article-title":"Natural products as platforms for the design of sphingolipid-related anticancer agents","volume":"117","author":"Delgado","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.ircmb.2016.06.006","article-title":"Metabolic Regulation of Apoptosis in Cancer","volume":"327","author":"Matsuura","year":"2016","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41419-023-06023-4","article-title":"Targeting SphK1\/2 by SKI-178 inhibits prostate cancer cell growth","volume":"14","author":"Jin","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/mc.23347","article-title":"Crucial role of glucosylceramide synthase in the regulation of stem cell-like cancer cells in B16F10 murine melanoma","volume":"60","author":"Ghosh","year":"2021","journal-title":"Mol. Carcinog."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hawkins, C.C., Jones, A.B., Gordon, E.R., Williford, S.E., Harsh, Y., Ziebro, J.K., Landis, C.J., Gc, S., Crossman, D.K., and Cooper, S.J. (2022). Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT Signaling. Cells, 11.","DOI":"10.3390\/cells11121873"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"21715","DOI":"10.1038\/s41598-022-26095-0","article-title":"Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy","volume":"12","author":"Kendall","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbalip.2013.08.011","article-title":"Ceramide synthesis in the epidermis","volume":"1841","author":"Rabionet","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1194\/jlr.RA120000671","article-title":"Comparative profiling and comprehensive quantification of stratum corneum ceramides in humans and mice by LC\/MS\/MS","volume":"61","author":"Kawana","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1194\/jlr.P030338","article-title":"Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients","volume":"53","author":"Janssens","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.bbamem.2014.05.023","article-title":"The role of ceramide chain length distribution on the barrier properties of the skin lipid membranes","volume":"1838","author":"Mojumdar","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.langmuir.1c01295","article-title":"Increased Levels of Short-Chain Ceramides Modify the Lipid Organization and Reduce the Lipid Barrier of Skin Model Membranes","volume":"37","author":"Uche","year":"2021","journal-title":"Langmuir"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"554","DOI":"10.36849\/JDD.7142","article-title":"Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment","volume":"22","author":"Draelos","year":"2023","journal-title":"J. Drugs Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bzioueche, H., Tamelghaghet, M., Chignon-Sicard, B., Bazile, N., Hauchecorne, P., Barbero Calder\u00f3n, M., Meunier, P., Rocchi, S., Passeron, T., and Tulic, M.K. (2023). Ceramide AD\u2122 Restores Skin Integrity and Function following Exposure to House Dust Mite. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119234"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/ijd.ijd_991_22","article-title":"The Efficacy of Moisturisers Containing Ceramide Compared with Other Moisturisers in the Management of Atopic Dermatitis: A Systematic Literature Review and Meta-Analysis","volume":"68","author":"Nugroho","year":"2023","journal-title":"Indian J. Dermatol."},{"key":"ref_50","first-page":"SF344607s3","article-title":"Supplement Individual Article: The Importance of a Healthy Skin Barrier From the Cradle to the Grave Using Ceramide-Containing Cleansers and Moisturizers: A Review and Consensus","volume":"22","author":"Schachner","year":"2023","journal-title":"J. Drugs Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.36849\/JDD.7168","article-title":"An International Evaluation of a Ceramide-Containing Hydrating Cleanser and Moisturizing Cream for the Improvement of Diabetes Mellitus-Related Xerosis","volume":"22","author":"Kirsner","year":"2023","journal-title":"J. Drugs Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1194\/jlr.RA120000639","article-title":"Skin barrier lipid enzyme activity in Netherton patients is associated with protease activity and ceramide abnormalities","volume":"61","author":"Wang","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/jdv.17914","article-title":"Analysis of the structure and function of the epidermal barrier in patients with ichthyoses-clinical and electron microscopical investigations","volume":"36","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"773","DOI":"10.36849\/jdd.7411","article-title":"Psoriasis and Skin Barrier Dysfunction: The Role of Gentle Cleansers and Moisturizers in Treating Psoriasis","volume":"22","author":"Kircik","year":"2023","journal-title":"J. Drugs Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/sj.cdd.4401019","article-title":"Control of ceramide-induced apoptosis by IGF-1: Involvement of PI-3 kinase, caspase-3 and catalase","volume":"9","author":"Kondo","year":"2002","journal-title":"Cell Death Differ."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/cdd.2014.128","article-title":"Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling","volume":"22","author":"Yabu","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"L1082","DOI":"10.1152\/ajplung.00172.2002","article-title":"Ceramide accumulation precedes caspase-3 activation during apoptosis of A549 human lung adenocarcinoma cells","volume":"284","author":"Ravid","year":"2003","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1101\/gad.12.13.1941","article-title":"Inhibition of the anti-apoptotic PI(3)K\/Akt\/Bad pathway by stress","volume":"12","author":"Zundel","year":"1998","journal-title":"Genes Dev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1074\/jbc.M110541200","article-title":"Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: Implications for growth arrest","volume":"277","author":"Bourbon","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.brainresrev.2008.10.001","article-title":"Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration","volume":"59","author":"Arboleda","year":"2009","journal-title":"Brain Res. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.4049\/jimmunol.167.10.5977","article-title":"Ceramide regulates lipopolysaccharide-induced phosphatidylinositol 3-kinase and Akt activity in human alveolar macrophages","volume":"167","author":"Monick","year":"2001","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.plipres.2007.03.001","article-title":"Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate","volume":"46","author":"Kihara","year":"2007","journal-title":"Prog. Lipid Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1194\/jlr.S091959","article-title":"New insights into functions of the sphingosine-1-phosphate transporter SPNS2","volume":"60","author":"Spiegel","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4419-6741-1_10","article-title":"Extracellular and intracellular actions of sphingosine-1-phosphate","volume":"688","author":"Strub","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s13287-022-03177-4","article-title":"New mechanism for mesenchymal stem cell microvesicle to restore lung permeability: Intracellular S1P signaling pathway independent of S1P receptor-1","volume":"13","author":"Ye","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"L840","DOI":"10.1152\/ajplung.00404.2010","article-title":"Photolysis of caged sphingosine-1-phosphate induces barrier enhancement and intracellular activation of lung endothelial cell signaling pathways","volume":"300","author":"Usatyuk","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.biocel.2009.01.001","article-title":"Sphingosine kinase 1 is essential for proteinase-activated receptor-1 signalling in epithelial and endothelial cells","volume":"41","author":"Billich","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1074\/jbc.M111423200","article-title":"Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling","volume":"277","author":"Xia","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"12649","DOI":"10.1074\/jbc.M109111200","article-title":"Involvement of sphingosine kinase in TNF-alpha-stimulated tetrahydrobiopterin biosynthesis in C6 glioma cells","volume":"277","author":"Vann","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e10592","DOI":"10.7554\/eLife.29849","article-title":"Correction: TRAF2 regulates TNF and NF-\u03baB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1","volume":"6","author":"Etemadi","year":"2017","journal-title":"Elife"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1194\/jlr.R046300","article-title":"An update on the biology of sphingosine 1-phosphate receptors","volume":"55","author":"Blaho","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/pr.110.003111","article-title":"International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature","volume":"62","author":"Chun","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jid.2019.02.010","article-title":"Human Keratinocytes Use Sphingosine 1-Phosphate and its Receptors to Communicate Staphylococcus aureus Invasion and Activate Host Defense","volume":"139","author":"Igawa","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Wilkins, G.C., Gilmour, J., Giannoudaki, E., Kirby, J.A., Sheerin, N.S., and Ali, S. (2023). Dissecting the Therapeutic Mechanisms of Sphingosine-1-Phosphate Receptor Agonism during Ischaemia and Reperfusion. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241311192"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Gray, N., Limberg, M.M., Wiebe, D., Weihrauch, T., Langner, A., Brandt, N., Br\u00e4uer, A.U., and Raap, U. (2022). Differential Upregulation and Functional Activity of S1PR1 in Human Peripheral Blood Basophils of Atopic Patients. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416117"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Jo, H., Shim, K., and Jeoung, D. (2022). The Crosstalk between Fc\u03b5RI and Sphingosine Signaling in Allergic Inflammation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213892"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/mi.2016.35","article-title":"Sphingosine-1-phosphate receptor-1 (S1P(1)) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease","volume":"10","author":"Karuppuchamy","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jdermsci.2016.01.002","article-title":"Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells","volume":"82","author":"Bock","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"H2698","DOI":"10.1152\/ajpheart.01065.2006","article-title":"Sphingosine-1-phosphate receptor expression in cardiac fibroblasts is modulated by in vitro culture conditions","volume":"292","author":"Landeen","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"tkad003","DOI":"10.1093\/burnst\/tkad003","article-title":"Sphingosine-1-phosphate derived from PRP-Exos promotes angiogenesis in diabetic wound healing via the S1PR1\/AKT\/FN1 signalling pathway","volume":"11","author":"Chen","year":"2023","journal-title":"Burn. Trauma."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jid.2020.09.026","article-title":"Sphingosine 1-Phosphate Receptor 2 Is Central to Maintaining Epidermal Barrier Homeostasis","volume":"141","author":"Igawa","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41401-020-0412-8","article-title":"Blockage of sphingosine-1-phosphate receptor 2 attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice","volume":"41","author":"Park","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.1618659114","article-title":"Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1","volume":"114","author":"Yanagida","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1346-8138.2010.01145.x","article-title":"Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002\u20132008","volume":"38","author":"Takahashi","year":"2011","journal-title":"J. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1346-8138.13212","article-title":"Detection of asymptomatic enthesitis in psoriasis patients: An onset of psoriatic arthritis?","volume":"43","author":"Takata","year":"2016","journal-title":"J. Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00128071-200405060-00012","article-title":"Calcipotriol\/betamethasone dipropionate: A review of its use in the treatment of psoriasis vulgaris","volume":"5","author":"Fenton","year":"2004","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_88","first-page":"918","article-title":"Treat to Target in Psoriasis: A Real-World Experience With Biologics and Adjunctive Topical Therapy","volume":"17","author":"Bagel","year":"2018","journal-title":"J. Drugs Dermatol."},{"key":"ref_89","first-page":"39","article-title":"Biologic Treatments of Psoriasis: An Update for the Clinician","volume":"15","author":"Brownstone","year":"2021","journal-title":"Biologics"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2217\/imt-2021-0096","article-title":"TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases","volume":"13","author":"Gonciarz","year":"2021","journal-title":"Immunotherapy"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"668","DOI":"10.55563\/clinexprheumatol\/e7ayu8","article-title":"JAK\/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis","volume":"39","author":"Crispino","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"S\u0142uczanowska-G\u0142\u0105bowska, S., Ziegler-Krawczyk, A., Szumilas, K., and Pawlik, A. (2021). Role of Janus Kinase Inhibitors in Therapy of Psoriasis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194307"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/13543776.2019.1567713","article-title":"Selective Tyk2 inhibitors as potential therapeutic agents: A patent review (2015\u20132018)","volume":"29","author":"He","year":"2019","journal-title":"Expert. Opin. Ther. Pat."},{"key":"ref_94","first-page":"e138","article-title":"English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis","volume":"50","author":"Saeki","year":"2023","journal-title":"J. Dermatol."},{"key":"ref_95","first-page":"73","article-title":"Updated Perspectives on Keratinocytes and Psoriasis: Keratinocytes are More Than Innocent Bystanders","volume":"12","author":"Choudhary","year":"2022","journal-title":"Psoriasis"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Nowowiejska, J., Baran, A., and Flisiak, I. (2021). Aberrations in Lipid Expression and Metabolism in Psoriasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126561"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Matwiejuk, M., Mysliwiec, H., Lukaszuk, B., Lewoc, M., Malla, H., Mysliwiec, P., Dadan, J., Chabowski, A., and Flisiak, I. (2023). The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411336"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5021\/ad.2013.25.3.321","article-title":"Altered levels of sphingosine and sphinganine in psoriatic epidermis","volume":"25","author":"Moon","year":"2013","journal-title":"Ann. Dermatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"109212","DOI":"10.1016\/j.clim.2022.109212","article-title":"Lipidomic profiling reveals metabolic signatures in psoriatic skin lesions","volume":"246","author":"Liu","year":"2023","journal-title":"Clin. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Moskot, M., Boche\u0144ska, K., Jak\u00f3bkiewicz-Banecka, J., Banecki, B., and Gabig-Cimi\u0144ska, M. (2018). Abnormal Sphingolipid World in Inflammation Specific for Lysosomal Storage Diseases and Skin Disorders. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010247"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/jid.2013.199","article-title":"Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model","volume":"133","author":"Nakajima","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"105305","DOI":"10.1016\/j.chemphyslip.2023.105305","article-title":"Comparative analysis of intercellular lipid organization and composition between psoriatic and healthy stratum corneum","volume":"254","author":"Uchino","year":"2023","journal-title":"Chem. Phys. Lipids"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/exd.14431","article-title":"Decrease of ceramides with long-chain fatty acids in psoriasis: Possible inhibitory effect of interferon gamma on chain elongation","volume":"31","author":"Kim","year":"2022","journal-title":"Exp. Dermatol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"\u0141uczaj, W., Wro\u0144ski, A., Domingues, P., Domingues, M.R., and Skrzydlewska, E. (2020). Lipidomic Analysis Reveals Specific Differences between Fibroblast and Keratinocyte Ceramide Profile of Patients with Psoriasis Vulgaris. Molecules, 25.","DOI":"10.3390\/molecules25030630"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0925-4439(93)90135-N","article-title":"Ceramide composition of the psoriatic scale","volume":"1182","author":"Motta","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/jid.2013.364","article-title":"Interferon-\u03b3 decreases ceramides with long-chain fatty acids: Possible involvement in atopic dermatitis and psoriasis","volume":"134","author":"Tawada","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00403-016-1709-9","article-title":"Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients","volume":"309","author":"Baran","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1038\/srep12017","article-title":"Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-\u03b1 treatment","volume":"5","author":"Checa","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_109","first-page":"e13988","article-title":"Therapeutic implications and role of serum sphingolipids on psoriasis severity after narrow band ultraviolet B treatment: A cross sectional controlled study","volume":"33","author":"Nada","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.5114\/ada.2019.91422","article-title":"Serum sphingolipid level in psoriatic patients with obesity","volume":"36","author":"Milewska","year":"2019","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jdermsci.2013.03.006","article-title":"Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis","volume":"71","author":"Schaper","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e14904","DOI":"10.15252\/emmm.202114904","article-title":"S1P defects cause a new entity of cataract, alopecia, oral mucosal disorder, and psoriasis-like syndrome","volume":"14","author":"Chen","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e19109","DOI":"10.1016\/j.heliyon.2023.e19109","article-title":"Xiaoyin Jiedu Granules may alleviate psoriasis-like skin diseases in mice by regulating sphingosine 1-phosphate receptor expression and reducing Th17 cells","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Syed, S.N., Raue, R., Weigert, A., von Knethen, A., and Br\u00fcne, B. (2019). Macrophage S1PR1 Signaling Alters Angiogenesis and Lymphangiogenesis During Skin Inflammation. Cells, 8.","DOI":"10.3390\/cells8080785"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1248\/bpb.b17-00939","article-title":"Validating a Selective S1P(1) Receptor Modulator Syl930 for Psoriasis Treatment","volume":"41","author":"Ji","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(14)60803-5","article-title":"Oral ponesimod in patients with chronic plaque psoriasis: A randomised, double-blind, placebo-controlled phase 2 trial","volume":"384","author":"Vaclavkova","year":"2014","journal-title":"Lancet"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1111\/ajd.13983","article-title":"A case of psoriasis and multiple sclerosis succesfully treated with concomitant fingolimod and secukinumab","volume":"64","author":"Megna","year":"2023","journal-title":"Australas. J. Dermatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"16802","DOI":"10.1111\/1346-8138.16802","article-title":"Generalized pustular psoriasis occurring in a patient with multiple sclerosis during treatment with fingolimod","volume":"50","author":"Ikumi","year":"2023","journal-title":"J. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2460\/ajvr.67.4.588","article-title":"In vitro evaluation of the effect of a novel immunosuppressive agent, FTY720, on the function of feline neutrophils","volume":"67","author":"Chen","year":"2006","journal-title":"Am. J. Vet. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1016\/j.bmcl.2018.07.044","article-title":"Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1","volume":"28","author":"Bell","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdermsci.2019.05.007","article-title":"Long-term Western diet intake leads to dysregulated bile acid signaling and dermatitis with Th2 and Th17 pathway features in mice","volume":"95","author":"Jena","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"9991175","DOI":"10.1155\/2021\/9991175","article-title":"The lncRNA H19\/miR-766-3p\/S1PR3 Axis Contributes to the Hyperproliferation of Keratinocytes and Skin Inflammation in Psoriasis via the AKT\/mTOR Pathway","volume":"2021","author":"He","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1096\/fj.10-179028","article-title":"Sphingosine-1-phospate receptor 4 (S1P\u2084) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model","volume":"25","author":"Schulze","year":"2011","journal-title":"Faseb. J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4049\/jimmunol.1403168","article-title":"S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-\u03b1 Production by Human Plasmacytoid Dendritic Cells","volume":"196","author":"Dillmann","year":"2016","journal-title":"J. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/eji.201948349","article-title":"S1PR4-dependent CCL2 production promotes macrophage recruitment in a murine psoriasis model","volume":"50","author":"Schuster","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2021.04.004","article-title":"Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing gd T cells in secondary lymph nodes","volume":"102","author":"Okura","year":"2021","journal-title":"J. Dermatol. Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s40265-021-01528-8","article-title":"Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis","volume":"81","year":"2021","journal-title":"Drugs"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_129","first-page":"265","article-title":"Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease","volume":"18","author":"Choden","year":"2022","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"104719","DOI":"10.1016\/j.cellimm.2023.104719","article-title":"Mocravimod, a S1P receptor modulator, increases T cell counts in bone marrow biopsies from patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"388\u2013389","author":"Dertschnig","year":"2023","journal-title":"Cell Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/jdv.18914","article-title":"Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE)","volume":"37","author":"Silverberg","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jdermsci.2017.11.003","article-title":"Modeling clinical efficacy of the S1P receptor modulator ponesimod in psoriasis","volume":"89","author":"Krause","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s40265-022-01762-8","article-title":"Ozanimod: A Review in Ulcerative Colitis","volume":"82","author":"Paik","year":"2022","journal-title":"Drugs"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"759276","DOI":"10.3389\/fimmu.2021.759276","article-title":"Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/19\/2352\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:58:09Z","timestamp":1760129889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/19\/2352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":134,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["cells12192352"],"URL":"https:\/\/doi.org\/10.3390\/cells12192352","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]}}}